[1]
S. Raut, R. K. Gujar, M. Ali, and F. Bhopalwala Ali, “UTILITY OF HBME1 IMMUNOSTAIN IN DIFFERENTIATING REACTIVE MESOTHELIAL CELLS LESIONS FROM MALIGNANT EPITHELIAL CELLS LESIONS IN SEROUS EFFUSIONS”, Asian J Pharm Clin Res, vol. 16, no. 6, pp. 53–55, Jun. 2023.